ReviewEuropean radiology2007
Magnetic resonance imaging of Alzheimer's disease.
Review in European radiology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 75 citations in OpenAlex.
- Article
- A comprehensive characterization of hippocampal feature ensemble serves as individualized brain signature for Alzheimer's disease: deep learning analysis in 3238 participants worldwide.European radiology · 2023Article
- Radiomics-Based Artificial Intelligence Differentiation of Neurodegenerative Diseases with Reference to the Volumetry.Life (Basel, Switzerland) · 2022Article
- The Shrinking Brain: Cerebral Atrophy Following Traumatic Brain Injury.Annals of biomedical engineering · 2019Review
- A review of β-amyloid neuroimaging in Alzheimer's disease.Frontiers in neuroscience · 2014Review
- The effect of galantamine on brain atrophy rate in subjects with mild cognitive impairment is modified by apolipoprotein E genotype: post-hoc analysis of data from a randomized controlled trial.Alzheimer's research & therapy · 2014Article
- Role of emerging neuroimaging modalities in patients with cognitive impairment: a review from the Canadian Consensus Conference on the Diagnosis and Treatment of Dementia 2012.Alzheimer's research & therapy · 2013Article
- Glyconanoparticle aided detection of β-amyloid by magnetic resonance imaging and attenuation of β-amyloid induced cytotoxicity.ACS chemical neuroscience · 2013Article
- Challenges of High-resolution Diffusion Imaging of the Human Medial Temporal Lobe in Alzheimer Disease.Topics in magnetic resonance imaging : TMRI · 2010Review
- Measurement of precuneal and hippocampal volumes using magnetic resonance volumetry in Alzheimer's disease.Journal of clinical neurology (Seoul, Korea) · 2010Article
- Automated MR morphometry to predict Alzheimer's disease in mild cognitive impairment.International journal of computer assisted radiology and surgery · 2010Article
- [MR spectroscopy in dementia].Der Radiologe · 2010Article
- Alzheimer's Disease: Fatty Acids We Eat may be Linked to a Specific Protection via Low-dose Aspirin.Aging and disease · 2010Article
- Magnetic resonance imaging of Alzheimer's disease: from diagnosis to therapeutic evaluation.Chinese journal of integrative medicine · 2010Review
- Volume changes in Alzheimer's disease and mild cognitive impairment: cognitive associations.European radiology · 2010Article
- The validity of biomarkers as surrogate endpoints in Alzheimer's disease by means of the Quantitative Surrogate Validation Level of Evidence Scheme (QSVLES).The journal of nutrition, health & aging · 2009Review
- Role of myo-inositol by magnetic resonance spectroscopy in early diagnosis of Alzheimer's disease in APP/PS1 transgenic mice.Dementia and geriatric cognitive disorders · 2009Article
- Altered neuronal gene expression in brain regions differentially affected by Alzheimer's disease: a reference data set.Physiological genomics · 2008Article
- Imaging readouts as biomarkers or surrogate parameters for the assessment of therapeutic interventions.European radiology · 2007Article
- Nanomedicine in the diagnosis and therapy of neurodegenerative disorders.Progress in polymer science · 2007Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 4 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A modern challenge for neuroimaging techniques is to contribute to the early diagnosis of neurodegenerative diseases, such as Alzheimer's disease (AD). Early diagnosis includes recognition of pre-demented conditions, such as mild cognitive impairment (MCI) or having a high risk of developing AD. The role of neuroimaging therefore extends beyond its traditional role of excluding other conditions such as neurosurgical lesions. In addition, early diagnosis would allow early treatment using currently available therapies or new therapies in the future. Structural imaging can detect and follow the time course of subtle brain atrophy as a surrogate marker for pathological processes. New MR techniques and image analysis software can detect subtle brain microstructural, perfusion or metabolic changes that provide new tools to study the pathological processes and detect pre-demented conditions. This review focuses on markers of macro- and microstructural, perfusion, diffusion and metabolic MR imaging and spectroscopy in AD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.